"Immunity, Humoral" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Antibody-mediated immune response. Humoral immunity is brought about by ANTIBODY FORMATION, resulting from TH2 CELLS activating B-LYMPHOCYTES, followed by COMPLEMENT ACTIVATION.
Concept/Terms
Humoral Immune Response- Humoral Immune Response
- Humoral Immune Responses
- Immune Response, Humoral
- Immune Responses, Humoral
- Response, Humoral Immune
Below are MeSH descriptors whose meaning is more general than "Immunity, Humoral".
Below are MeSH descriptors whose meaning is more specific than "Immunity, Humoral".
This graph shows the total number of publications written about "Immunity, Humoral" by people in Harvard Catalyst Profiles by year, and whether "Immunity, Humoral" was a major or minor topic of these publication.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2008 | 0 | 1 | 1 |
| 2009 | 2 | 4 | 6 |
| 2010 | 6 | 9 | 15 |
| 2011 | 6 | 9 | 15 |
| 2012 | 11 | 12 | 23 |
| 2013 | 5 | 8 | 13 |
| 2014 | 5 | 15 | 20 |
| 2015 | 5 | 12 | 17 |
| 2016 | 10 | 6 | 16 |
| 2017 | 12 | 13 | 25 |
| 2018 | 11 | 11 | 22 |
| 2019 | 12 | 14 | 26 |
| 2020 | 10 | 20 | 30 |
| 2021 | 3 | 11 | 14 |
Below are the most recent publications written about "Immunity, Humoral" by people in Profiles.
-
Immunogenicity and efficacy of one and two doses of Ad26.COV2.S COVID vaccine in adult and aged NHP. J Exp Med. 2021 07 05; 218(7).
-
Protective efficacy of Ad26.COV2.S against SARS-CoV-2 B.1.351 in macaques. Nature. 2021 08; 596(7872):423-427.
-
Immunomodulation as Treatment for Severe Coronavirus Disease 2019: A Systematic Review of Current Modalities and Future Directions. Clin Infect Dis. 2021 06 15; 72(12):e1130-e1143.
-
Immune age and biological age as determinants of vaccine responsiveness among elderly populations: the Human Immunomics Initiative research program. Eur J Epidemiol. 2021 Jul; 36(7):753-762.
-
Immunogenicity of Ad26.COV2.S vaccine against SARS-CoV-2 variants in humans. Nature. 2021 08; 596(7871):268-272.
-
Are We Forgetting About IgA? A Re-examination of Coronavirus Disease 2019 Convalescent Plasma. Transfusion. 2021 06; 61(6):1740-1748.
-
CD8+ T cells contribute to survival in patients with COVID-19 and hematologic cancer. Nat Med. 2021 07; 27(7):1280-1289.
-
Immunogenicity of the Ad26.COV2.S Vaccine for COVID-19. JAMA. 2021 04 20; 325(15):1535-1544.
-
Adjuvanting a subunit COVID-19 vaccine to induce protective immunity. Nature. 2021 06; 594(7862):253-258.
-
Comorbid illnesses are associated with altered adaptive immune responses to SARS-CoV-2. JCI Insight. 2021 03 22; 6(6).